Amphastar Pharmaceuticals, Inc. (AMPH Quick QuoteAMPH - Free Report) is a specialty pharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AMPH’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Amphastar Pharmaceuticals could be a solid choice for investors.

Current Quarter Estimates for AMPH

In the past 30 days, 1 estimate has gone higher for Amphastar Pharmaceuticals while none has gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 4 cents a share 30 days ago, to a loss of 2 cents today, a move of 50%.

Current Year Estimates for AMPH

Meanwhile, Amphastar Pharmaceuticals’ current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from a loss of 6 cents per share 30 days ago to earnings of 5 cents per share today, a significant increase.

Bottom Line

The stock has also started to move higher lately, adding 18.2% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>